Module5

MODULE 5: Patent Medicine Vendor (PMV) Interview
Facility/PMV Code:
Interviewer Code:
SPEAK TO THE OWNER OR PRIMARY WORKER OF THE SHOP:
THE PERSON AVAILABLE WHO IS MOST INVOLVED WITH SALES IN THE LAST DAY IS THE FIRST CHOICE, IF AVAILABLE
INTRODUCE YOURSELF AND READ THE CONSENT FORM.
QUESTIONS
CODING CLASSIFICATION
………………………………………………………….
………………………………….
Mobile ………………………………………………………….
………………………………………………………….
Female ………………………………………………………….
03 How long have you been a Patent Medicine Vendor (PMV)? 04 What is your highest educational level? …………………………………………………….
…………………………………………………….
…………………………………………… 502 Approximately how many persons with either malaria or fever came to your shop/store for treatment yesterday (or last day the shop had someone with fever/malaria)? …………………………………………………………………….
ACTs
503 What treatments did these people purchase for their fever/malaria? Artemether-Lumefantrine (any brand, e.g., Coartem) Dihydroartemisinin-Piperaquine=Trimethoprim (Expect many different brands to be available: Artemisinin-derivative monotherapies
identify the active ingredients of drugs sold) …………………………………………… …………………………………………… Circle all that apply
…………………………………………… ………………………………….
Other antimalarials
…………………………………………… …………………………………………… …………………………………………… …………………………………………… ………………………………….
…………………………………………… …………………………………………… ACTs
504 May I please see all the antimalaria medications you have in stock? Artemether-Lumefantrine (any brand, e.g., Coartem) Dihydroartemisinin-Piperaquine-Trimethoprim (Observe each antimalarial package available) Artemisinin-derivative monotherapies
…………………………………………… Circle all formulations that are available in the shop
…………………………………………… …………………………………………… ………………………………….
Other antimalarials
…………………………………………… …………………………………………… …………………………………………… …………………………………………… …………………………………………… …………………………………………… WHICH ACT BRANDS or TRADEMARKS DO YOU HAVE AVAILABLE? ………………………………………………………………………………… ………………………………………………………………………………… ARSUAMOON
………………………………………………………………………………… ………………………………………………………………………………… ………………………………………………………………………………… ………………………………………………………………………………… NEXANATE?
………………………………………………………………………………… ………………………………………………………………………………… ………………………………………………………………………………… ………………………………………………………………………………… ………………………………………………………………………………… ………………………………………………………………………………… 506 FOR EACH OF THE FOLLOWING 2 ACT FORMULATIONS, Artemether-Lumefantrine (any brand, e.g., Coartem) IF THERE IS MORE THAN ONE BRAND/TYPE OF ACT OF THE SAME FORMULATION, RECORD THE LEAST COST ONE.
Record the price in Naira
Enter '9999' if that particular formulation is not available
507 FOR EACH OF THE FOLLOWING 2 ACT FORMULATIONS, ASK TO SEE ALL ACTs IN THE SHOP AS A FIRST STEP.
Artemether-Lumefantrine (any brand, e.g., Coartem) Circle Y if any type of that formulation is expired
Circle N if no type of that formulation is expired
Circle NA if that formulation is not available in the shop.
508 [PULL OUT THE TWO TYPES ACTs YOU HAVE BROUGHT WITH YOU].
YOU SHOULD SHOW THE PMV THE MOST COMMONLY AVAILABLE BRAND OF BOTH TYPES OF RECOMMENDED ACTS.
…………………………………… (Artemether-Lumefantrine, Artesunate-Amodiaquine) …………………………………… FOR EACHOF THE 2 ACTs YOU BROUGHT, ASK THE SHOP KEEPER WHAT THE DOSE IS FOR A 2-YEAR OLD CHILD.
2 year old dosage:
1a 20mg artemether + 120mg Lumefantrine per tablet
Circle Y if dose reported is correct
1b 1 tablet twice daily for 3 days
Circle N if dose reported is incorrect
2a 50 mg artesunate + 135 mg amodiaquine
2b Fixed-dose combination tablets: 1 tablet per day for 3 days
2c Co-blistered tablets: 1 tablet of each per day for 3 days
509 Have you received training in any topic related to malaria? What was included in the most recent training? DO NOT READ THE LIST, CIRCLE OPTIONS MENTIONED.
PROBE ON DATES OF MOST RECENT TRAINING.
02 Promotion of Insecticide treated bednets 04 Stop use of chloroquine and/or SP for treatment 510 For children with fever/malaria… What are danger signs or symptoms that should cause a child to be taken to a hospital for help? …………………………………………….
Circle Y next to any sign THAT IS mentioned
E Very sick child (not able to sit or stand) Circle N next to any sign THAT IS NOT mentioned
…………………………………………….
H Child has not improved or getting worse after 2 days 511 Do you know the government recommendations on the treatment of malaria? A ACTs for treatment of uncomplicated malaria/home treatment Circle Y next to any policy THAT IS mentioned
B Disuse of chloroquine and SP for treatment Circle N next to any policy THAT IS NOT mentioned
D Antimalarials should be given in single treatment packs E SP to be provided at least twice during pregnancy F Treatment sought for febril cases within 24 hrs of onset of 512 Do you know the government recommendations on the prevention of malaria? A ITNs should be used by persons at risk for malaria Circle Y next to any policy THAT IS mentioned
Circle N next to any policy THAT IS NOT mentioned
………………………………………………………………………………… ………………………………………………………………………………… ………………………………………………………………………………… …………………………………………………………………………………

Source: http://www.thephss.org/hfa/pdf_files/module5.pdf

Http://healthandenergy.com/diseases_linked_to_molds.htm

[ H & E Home ] [ Mold Harms Babies ] [ Mold's Harmful Effects ] [ Fungi and Indoor Air Quality ] [ Aspergillus ] [ Chaetomium ] [ Cladosporium ] [ Fusarium ] [ Penicillium ] [ Stachybotrys ] [ Diseases Linked to Molds ] [ Mold and Indoor Air Quality ] Diseases Caused by Molds in Humans Bulletin of the World Health Organization By Peraica, M.; Radic, B.; Lucic, A.; Pavlovic, M.

Natureplus e

natureplus e.V. Vergaberichtlinie 1107 HOLZSPANBETON - MANTELSTEINE UND PLATTEN Vergaberichtlinie 1107 HOLZSPANBETON - MANTELSTEINE UND PLATTEN Stand: Mai 2009 Seite 2 von 9 Präambel Die natureplus-Vergabekriterien sind hierarchisch aufgebaut. Jedes Produkt, das nach einer Produkt-Vergaberichtlinie geprüft wird, muss zugleich auch die Anforderungen der Basiskrit

Copyright © 2010 Medicament Inoculation Pdf